Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CY3J | ISIN: CA31685W1068 | Ticker-Symbol: N/A
Frankfurt
21.05.25 | 19:48
0,010 Euro
0,00 % 0,000
1-Jahres-Chart
FILAMENT HEALTH CORP Chart 1 Jahr
5-Tage-Chart
FILAMENT HEALTH CORP 5-Tage-Chart

Aktuelle News zur FILAMENT HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.06.Filament Health Enters Into Exclusive License Agreement With University Of Alabama At Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder2
11.06.Filament Health Announces Authorization Of Phase 2 Clinical Trial Studying Botanical Psilocybin For Prolonged Grief Disorder1
28.05.Filament Health Announces Transition From Otcqb To Otc Pink Limited3
22.05.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025613The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT...
► Artikel lesen
22.05.XFRA 7QS: AUSSETZUNG/SUSPENSION199DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH...
► Artikel lesen
20.05.Filament Health Corp: Filament shares to delist from Cboe Canada May 211
19.05.Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada117VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic...
► Artikel lesen
FILAMENT HEALTH Aktie jetzt für 0€ handeln
09.05.Filament Health reports Q1 results1
09.05.Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights48VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic...
► Artikel lesen
09.04.Filament Health Corp: Filament receives U.S. FDA OK for PEX010 study1
09.04.Filament Health Announces Fda Authorization Of Phase 2 Clinical Trial Studying Pex010, The Company's Botanical Psilocybin Drug Candidate, In Opioid Use Disorder2
04.04.Filament Health to raise C$0.9M, delist from Cboe Canada1
04.04.Filament Health Corp: Filament Health arranges $900,000 private placement2
04.04.Filament Health Corp.: Filament Health Announces Private Placement And Intention To Voluntarily Delist From Cboe Canada125Financing driven by existing investor Negev and Filament's Board of Directors Company also announces intention to voluntarily delist from Cboe Canada VANCOUVER...
► Artikel lesen
01.04.Filament Health Corp.: Filament Health Reports Q4 And Year End 2024 Financial Results And Operational Highlights83VANCOUVER, BC, April 1, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic...
► Artikel lesen
01.04.Filament Health reports FY results1
17.03.Filament Health Corp: Filament Health talks PEX010 safety data1
17.03.Filament Health Corp.: Filament Health Announces Positive Data From Phase 2 Study Of Pex010 In Patients With Alcohol Use Disorder74Open-label study at Psychiatric Centre Copenhagen found that alcohol consumption significantly decreased amongst participants dosed with Filament's botanical psilocybin...
► Artikel lesen
06.02.Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference452Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as...
► Artikel lesen
22.01.Filament Health Corp: Filament Health ships PEX010 to UW-Madison1
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1